Adverse drug reaction reporting via mobile applications: A narrative review

D Leskur, J Bozic, D Rusic, AS Perisin… - International journal of …, 2022 - Elsevier
Introduction Pharmacovigilance importance has increased in the last few decades and it has
led to rise in awareness of adverse drug reaction reporting by both patients and health care …

Facilitators and barriers to uptake of the med safety mobile app for adverse drug reaction reporting by health workers in Uganda: a qualitative study

R Kiguba, H Zakumumpa, HB Ndagije, N Mwebaza… - Drug Safety, 2023 - Springer
Abstract Introduction Adverse drug reactions (ADRs) are an important public health
challenge worldwide; however, pharmacovigilance systems are plagued by under-reporting …

Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making

YK Khoo, JCW Lim, WC Tan-Koi, NS Kitikiti… - Drug Safety, 2024 - Springer
Pharmacovigilance involves a continuous process of evaluating, monitoring and
communicating the safety profile of a medicine throughout its life cycle. This process …

Improving adverse drug event reporting by healthcare professionals

G Shalviri, N Mohebbi, F Mirbaha… - Cochrane Database …, 2024 - cochranelibrary.com
Background Adverse drug events, encompassing both adverse drug reactions and
medication errors, pose a significant threat to health, leading to illness and, in severe cases …

The evolution of pharmacovigilance ecosystems: Does Moore's law invite the use of Occam's razor?

M Mueller, DJ Lewis, A Alexe - British Journal of Clinical …, 2023 - Wiley Online Library
Aims Moore's law predicts the doubling of complexity of integrated circuits every 2 years;
Kryder's corollary assumes a doubling of data storage every 13 months. With the increasing …

[HTML][HTML] Surveillance des effets indésirables lors des campagnes de la chimioprévention du paludisme saisonnier chez les enfants de 3-59 mois au Burkina Faso

J Ouoba, S Lankoandé-Haro, S Fofana, AP Nacoulma… - Sante Publique, 2023 - cairn.info
Introduction: La chimioprévention du paludisme saisonnier (CPS) par l'administration en
masse de la sulfadoxine-pyriméthamine+ amodiaquine (SPAQ) permet de réduire le …